Josh Mandel-Brehm insider trades

Open-market stock purchases and sales by Josh Mandel-Brehm, Chief Executive Officer at Camp4 Therapeutics Corp, from SEC Form 4 filings since Oct 3, 2024.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +99%.

Recent trades

DateStockTradeValue
Aug 3, 2026CAMP Camp4 Therapeutics CorpBought$10.8K
May 20, 2026PMN ProMIS Neurosciences IncBought (not open market)—
May 20, 2026PMN ProMIS Neurosciences IncBought (not open market)—
Apr 1, 2026CAMP Camp4 Therapeutics CorpBought (not open market)—
Dec 11, 2025CAMP Camp4 Therapeutics CorpBought (not open market)—

Companies traded

  • CAMP Camp4 Therapeutics Corp: 2 buys, last Aug 3, 2026
  • PMN ProMIS Neurosciences Inc: other filings, last May 20, 2026

Get free alerts when Josh Mandel-Brehm files a new trade →